Angiodynamics Inc. Stock
Price
Target price
€8.70
€8.70
-1.140%
-0.1
-1.140%
€13.00
03.02.26 / Stuttgart Stock Exchange
WKN: A0B9A5 / Name: AngioDynamics / Stock / Healthcare Equipment & Supplies / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Angiodynamics Inc. Stock
A loss of -1.140% shows a downward development for Angiodynamics Inc..
The community is currently still undecided about Angiodynamics Inc. with 1 Buy predictions and 0 Sell predictions.
As a result the target price of 13 € shows a positive potential of 49.43% compared to the current price of 8.7 € for Angiodynamics Inc..
Pros and Cons of Angiodynamics Inc. in the next few years
Pros
?
B****
?
M***** P*******
?
S********** s********
Cons
?
G***** c******* t* c**********
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Angiodynamics Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Angiodynamics Inc. | -1.140% | 2.353% | -18.692% | -17.925% | -18.692% | -28.099% | -44.231% |
| SI-BONE Inc | -0.720% | -2.837% | -17.964% | -16.970% | -18.935% | - | - |
| Orasure Tech | 0.000% | 9.821% | 21.782% | -35.602% | 19.417% | -51.287% | -79.500% |
| Lantheus Holdings Inc | -1.450% | -1.028% | -2.717% | -35.764% | -2.343% | -0.250% | - |
News
Why AngioDynamics Stock Is Sinking Today
Shares of AngioDynamics (NASDAQ: ANGO) were sinking 13.1% as of 11:02 a.m. ET. The sell-off came after the medical technology company announced its third-quarter results before the market open.
Why Did AngioDynamics Stock Pop Today?
AngioDynamics (NASDAQ: ANGO) stock soared 10.5% through 11:25 a.m. ET Thursday after beating on "earnings" (sort of) this morning.
Heading into the report, analysts forecast AngioDynamics would lose